Elevated Cardiac Troponin Levels in Geriatric Patients Without ACS: Role of Comorbidities.

Autor:	Sedighi SM; Geriatric Unit, Faculty of Medicine, Sherbrooke University, Sherbrooke, Quebec, Canada., Fulop T; Geriatric Unit, Faculty of Medicine, Sherbrooke University, Sherbrooke, Quebec, Canada., Mohammadpour A; Department of Mathematics and Statistics, Faculty of Science, McGill University, Montreal, Quebec, Canada., Nguyen M; Cardiology Unit, Faculty of Medicine, Sherbrooke University, Sherbrooke, Quebec, Canada., Prud'Homme P; Cardiology Unit, Faculty of Medicine, Sherbrooke University, Sherbrooke, Quebec, Canada., Khalil A; Geriatric Unit, Faculty of Medicine, Sherbrooke University, Sherbrooke, Quebec, Canada.
Jazyk:	angličtina
Zdroj:	CJC open [CJC Open] 2020 Jul 25; Vol. 3 (3), pp. 248-255. Date of Electronic Publication: 2020 Jul 25 (Print Publication: 2021).
DOI:	10.1016/j.cjco.2020.07.017
Abstrakt:	Background: Elevated levels of cardiac troponin T as measured by a high-sensitivity test (hscTnT) are common in geriatric patients with a large spectrum of comorbidities but without acute coronary syndrome (ACS). However, the relative contribution of individual comorbidities has never been clearly addressed. This study aimed to determine the relationship between hscTnT elevation as a response variable and individual comorbidities, and to estimate the impact of individual comorbidities on hscTnT elevation in geriatric patients free of ACS. Methods: A nonexperimental, retrospective, matched, longitudinal cohort study was designed to evaluate the files of 7062 geriatric patients (aged ≥ 65 years) without ACS. The hscTnT levels of the patients have already been measured in all evaluated medical records. The dataset was split into 2 groups (0 and 1) based on the individual comorbidity (0 and 1) and hscTnT levels (≤ 14 ng/L = 0 and > 14 ng/L = 1). Results: Our results show that although age was positively and significantly correlated with hscTnT (r = 0.17, P < 0.0001), the likelihood of experiencing elevated hscTnT levels in older individuals after having excluded ACS was related to the presence of comorbidities independently of their number ( P < 0.0001). The regression coefficients (β) associated with renal insufficiency (0.71), cardiomyopathy (0.63), chronic obstructive pulmonary disease (0.30), diabetes (0.25), and anemia (0.22) indicated that there exists a significant association between these comorbidities and the elevated hscTnT levels ( P < 0.001). The receiver operating characteristic curve for predictive modeling was estimated at 71% ( P < 0.0001). Conclusions: Elevated hscTnT levels were mostly associated with renal insufficiency, cardiac myopathies, chronic obstructive pulmonary disease, diabetes, and anemia in geriatric patients without ACS. Developing guidelines to accurately evaluate hscTnT elevation in geriatric patients with comorbidities, without ACS, is clinically essential. (© 2020 Canadian Cardiovascular Society. Published by Elsevier Inc.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu